Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 16Not yet recruiting 6Active not recruiting 5Enrolling by invitation 2Completed 2

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 5Tumor-Agnostic 1

Conditions

Breast Neoplasms 52Neoplasms 36Colorectal Neoplasms 33Prostatic Neoplasms 31Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 30Pancreatic Neoplasms 21Multiple Myeloma 16Recurrence 14Ovarian Neoplasms 14Uterine Cervical Neoplasms 12Leukemia, Myeloid, Acute 11Carcinoma, Hepatocellular 11Neoplasm Metastasis 10Head and Neck Neoplasms 10Brain Neoplasms 10Melanoma 9Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Rectal Neoplasms 8Advanced Solid Tumors 8Triple Negative Breast Neoplasms 7Small Cell Lung Carcinoma 7Glioblastoma 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Glioma 6Esophageal Neoplasms 6Colonic Neoplasms 6

Interventions

enzalutamide 1PF06821497 1Negative-Pressure Wound Therapy 1Docetaxel 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma × 30 days × Clear all
NCT07574541 2026-06-05

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
52 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Prostatic Neoplasms

NCT06906471 2026-06-04

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Antelope Surgical Solutions, Inc

Phase 1/2 Not yet recruiting
10 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07489820 2026-05-22

AAPICO

Centre Hospitalier Departemental Vendee

Phase NA Not yet recruiting
100 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT07598032 2026-05-20

iCCaRE

University of Ilorin Teaching Hospital

Phase 3 Not yet recruiting
200 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07316686 2026-05-18

Lutécio

Instituto do Cancer do Estado de São Paulo

Phase 1 Not yet recruiting
18 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07592910 2026-05-18

MOMENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡